HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Lin Selected Research

Tissue Plasminogen Activator (Alteplase)

10/2017Tissue-type plasminogen activator modulates macrophage M2 to M1 phenotypic change through annexin A2-mediated NF-κB pathway.
3/2015Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathway.
10/2014Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways.
1/2014Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms.
3/2008tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Lin Research Topics

Disease

96Neoplasms (Cancer)
04/2024 - 02/2005
44Narcolepsy
01/2023 - 06/2002
34Inflammation (Inflammations)
11/2023 - 02/2004
22Neoplasm Metastasis (Metastasis)
11/2023 - 04/2010
21Breast Neoplasms (Breast Cancer)
12/2023 - 04/2010
18Cataplexy
11/2015 - 11/2006
16Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2003
13Chronic Obstructive Pulmonary Disease (COPD)
02/2024 - 01/2021
13Infections
06/2023 - 10/2014
11Fibrosis (Cirrhosis)
03/2023 - 03/2008
11Atherosclerosis
01/2023 - 05/2009
10Body Weight (Weight, Body)
02/2024 - 11/2005
9COVID-19
05/2024 - 03/2020
9Sleep Wake Disorders
10/2020 - 12/2003
8Hypoxia (Hypoxemia)
01/2023 - 05/2009
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 03/2015
8Insulin Resistance
01/2022 - 08/2007
8Thrombosis (Thrombus)
11/2019 - 09/2007
7Wounds and Injuries (Trauma)
04/2024 - 01/2017
7Lung Injury
01/2023 - 07/2009
7Parkinson Disease (Parkinson's Disease)
01/2023 - 07/2005
7Human Influenza (Influenza)
01/2022 - 10/2013
7Lung Neoplasms (Lung Cancer)
08/2020 - 01/2013
6Type 2 Diabetes Mellitus (MODY)
02/2024 - 01/2014
6Hepatitis
02/2023 - 10/2014
6Alzheimer Disease (Alzheimer's Disease)
01/2023 - 02/2002
6Sleep Apnea Syndromes (Sleep Apnea)
07/2022 - 12/2004
6Carcinogenesis
01/2022 - 08/2008
6Carcinoma (Carcinomatosis)
01/2022 - 03/2011
6Myocardial Infarction
11/2021 - 08/2005
6Glioma (Gliomas)
11/2021 - 08/2008
6Massive Hepatic Necrosis
08/2021 - 07/2014
6Adenocarcinoma of Lung
11/2020 - 12/2007
6Disorders of Excessive Somnolence (Hypersomnia)
12/2013 - 05/2003
5Disease Progression
05/2024 - 12/2011
5Triple Negative Breast Neoplasms
01/2023 - 01/2021
5Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 03/2014
5Necrosis
01/2020 - 05/2011
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2018 - 07/2014
5Sleepiness
11/2015 - 05/2003
4Coronary Artery Disease (Coronary Atherosclerosis)
03/2024 - 08/2013
4Adenocarcinoma
01/2024 - 01/2020
4Severe Fever with Thrombocytopenia Syndrome
05/2023 - 01/2021
4Pneumonia (Pneumonitis)
03/2023 - 01/2013
4Ischemia
01/2023 - 01/2017
4Reperfusion Injury
12/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

52Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2003
36OrexinsIBA
01/2023 - 06/2002
26Biomarkers (Surrogate Marker)IBA
08/2023 - 01/2014
11AntigensIBA
01/2024 - 03/2007
11Glucose (Dextrose)FDA LinkGeneric
12/2023 - 10/2010
11CytokinesIBA
11/2023 - 02/2004
11HLA Antigens (Human Leukocyte Antigens)IBA
01/2023 - 01/2007
10LipopolysaccharidesIBA
02/2023 - 01/2013
10LipidsIBA
01/2023 - 01/2014
10MicroRNAs (MicroRNA)IBA
01/2023 - 09/2011
10HLA-DQB1 antigen (HLA DQB1)IBA
11/2015 - 06/2006
9DNA (Deoxyribonucleic Acid)IBA
10/2023 - 12/2007
8Therapeutic UsesIBA
11/2023 - 08/2007
8Messenger RNA (mRNA)IBA
01/2023 - 04/2012
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 10/2006
7Peptides (Polypeptides)IBA
01/2023 - 04/2012
7AntibodiesIBA
08/2022 - 08/2009
7Triglycerides (Triacylglycerol)IBA
01/2022 - 02/2011
7Apolipoproteins E (ApoE)IBA
12/2020 - 07/2012
7AutoantibodiesIBA
01/2019 - 02/2004
7Small Interfering RNA (siRNA)IBA
12/2017 - 03/2011
6GoldIBA
12/2023 - 01/2021
6GalactosamineIBA
02/2023 - 07/2014
6C-Reactive ProteinIBA
01/2023 - 08/2006
6Long Noncoding RNAIBA
01/2023 - 03/2015
6RNA (Ribonucleic Acid)IBA
02/2021 - 10/2019
5Indicators and Reagents (Reagents)IBA
12/2023 - 01/2021
5Phosphotransferases (Kinase)IBA
01/2023 - 01/2019
5Insulin (Novolin)FDA Link
06/2022 - 09/2010
5Amyloid (Amyloid Fibrils)IBA
10/2021 - 02/2002
5pandemrixIBA
01/2021 - 01/2017
5EnzymesIBA
01/2020 - 01/2011
5Tissue Plasminogen Activator (Alteplase)FDA Link
10/2017 - 03/2008
5HLA-DRB1 Chains (HLA DRB1)IBA
11/2008 - 01/2004
4Ritonavir (Norvir)FDA Link
05/2024 - 09/2023
4Hemoglobins (Hemoglobin)IBA
02/2024 - 01/2011
4SmokeIBA
01/2024 - 11/2022
4Metformin (Glucophage)FDA LinkGeneric
11/2023 - 10/2015
4IronIBA
11/2023 - 01/2016
4Anti-Bacterial Agents (Antibiotics)IBA
11/2023 - 01/2019
4NitrogenIBA
08/2023 - 06/2016
4theanineIBA
01/2023 - 01/2020
4Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2014
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 10/2014
4Transcription Factors (Transcription Factor)IBA
01/2023 - 04/2004
4NF-kappa B (NF-kB)IBA
01/2022 - 02/2004
4LigandsIBA
01/2022 - 01/2012
4SpectrinIBA
01/2022 - 11/2014

Therapy/Procedure

54Therapeutics
12/2023 - 07/2004
10Drug Therapy (Chemotherapy)
03/2023 - 04/2013
8Immunotherapy
01/2024 - 04/2017
7Radiotherapy
01/2024 - 09/2016
6Transplantation
02/2022 - 01/2007
5Stents
11/2014 - 04/2013